Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TECLISTAMAB vs TELAPREVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TECLISTAMAB vs TELAPREVIR: Safety Overview

Metric TECLISTAMAB TELAPREVIR
Total FAERS Reports 1,221 6,420
Deaths Reported 269 195
Death Rate 22.0% 3.0%
Hospitalizations 540 1,040
Average Patient Age 66.5 yrs 53.9 yrs
% Female Patients 45.7% 45.4%
FDA Approval Date N/A May 23, 2011
Manufacturer Janssen Biotech, Inc. N/A
Route SUBCUTANEOUS N/A
Marketing Status N/A Discontinued